RetiPharma (private company)

See something wrong or missing? Let us know
Offices:
Copenhagen
Business model:
B2B
Investors:
Novo A/S

Total investments received (USD) - 1.46M

RetiPharma is a biotech company focused on developing novel treatments for neurodegenerative eye diseases and forward & backward translatability

Companies with similar profile to RetiPharma:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)